What is Zacks Research’s Estimate for ALLO Q2 Earnings?
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Research analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Allogene Therapeutics in a report released on Tuesday, June 3rd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of ($0.27) for the quarter, up from […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Research analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Allogene Therapeutics in a report released on Tuesday, June 3rd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of ($0.27) for the quarter, up from […]
